TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,000 | -71.2% | 35,000 | -20.5% | 0.00% | -66.7% |
| Q1 2019 | $59,000 | +18.0% | 44,000 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $50,000 | -58.7% | 44,000 | 0.0% | 0.01% | -54.5% |
| Q3 2018 | $121,000 | -22.9% | 44,000 | 0.0% | 0.01% | -21.4% |
| Q2 2018 | $157,000 | +18.9% | 44,000 | +2.3% | 0.01% | +16.7% |
| Q1 2018 | $132,000 | -30.2% | 43,000 | +43.3% | 0.01% | -29.4% |
| Q4 2017 | $189,000 | -7.8% | 30,000 | 0.0% | 0.02% | -10.5% |
| Q3 2017 | $205,000 | -4.2% | 30,000 | 0.0% | 0.02% | -9.5% |
| Q2 2017 | $214,000 | -22.5% | 30,000 | 0.0% | 0.02% | -22.2% |
| Q1 2017 | $276,000 | +128.1% | 30,000 | 0.0% | 0.03% | +125.0% |
| Q4 2016 | $121,000 | +31.5% | 30,000 | +25.0% | 0.01% | +50.0% |
| Q3 2016 | $92,000 | -10.7% | 24,000 | 0.0% | 0.01% | -11.1% |
| Q2 2016 | $103,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |